Vaxtex Cotfab Limited Reports Audited Financial Results for Quarter and Year Ended March 31, 2026
Vaxtex Cotfab Limited announced the approval of its audited standalone financial results for the quarter and year ended March 31, 2026, on May 25, 2026. The Board of Directors of the company approved the audited financial results, along with the Statement of Assets and Liabilities and the Statement of Cash flow for the period.The financial results provide an overview of the company's performance up to March 31, 2026, detailing key metrics for revenue, expenses, and net profit across quarterly and annual cycles.
Quarterly and Annual Financial Performance
The company reported its financial performance in the quarter and year ended March 31, 2026, compared to previous periods. The following table summarizes the audited standalone financial results:| Particulars | Quarter Ended 31-03-2026 | Quarter Ended 31-12-2025 | Quarter Ended 31-03-2025 | Year Ended 31-03-2026 | Year Ended 31-03-2025 |
|---|---|---|---|---|---|
| 1. Income | |||||
| Revenue from Operations | - | 887.99 | 52533 | 1,116.64 | 525.33 |
| Other Income Total Income | 49.81 | 155.64 | 106.39 | 325.90 | 112.90 |
| Total Income | 49.81 | 1,043.63 | 631.72 | 1,442.54 | 638.23 |
| 2. Expenses | |||||
| Purchase of stock-in-trade | (1.80) | 594.71 | 504.76 | 1,584.27 | 484.12 |
| Employees benefits expense | 3.44 | 3.66 | 217 | 1822 | 855 |
| Finance costs | 186 | 186 | 6.18 | 731 | 1125 |
| Depreciation and amortisation expense Other Expenses | 6.82 | 8.41 | 6.61 | 38.55 | 61.27 |
| Total Expenses | 10.32 | 658.41 | 542.61 | 936.39 | 597.07 |
| 3. Profit Before Tax (1-2) | 39.49 | 385.22 | 89.11 | 506.15 | 41.16 |
| Total Tax Expenses | (39.36) | (9.39) | (42.50) | (46.40) | (47.20) |
| 5. Net Profit for the period (3-4) | 78.85 | 394.61 | 13161 | 552.55 | 88.36 |
| 7. Total comprehensive income net of taxes | 78.85 | 394.61 | 131.61 | 552.55 | 88.36 |
| Basic & Diluted EPS | 0.04 | 0.21 | 0.07 | 0.30 | 0.05 |
Statement of Assets and Liabilities
The audited standalone statement of assets and liabilities as of March 31, 2026, shows the company's financial position compared to the previous year.| Particulars | As at March 31, 2026 (X In Lakhs) | As at March 31, 2025 (X In Lakhs) |
|---|---|---|
| ASSETS | ||
| Non-Current Assets | ||
| Property, Plant and Equipment | 0.08 | 104.00 |
| Investments | 7.5 | 635.73 |
| Other Non Current Financial Assets | 47.25 | 4163 |
| Deferred Tax Assets (Net) | 64.86 | 18.13 |
| Total Non-Current Assets | 119.69 | 799.49 |
| Current Assets | ||
| Inventories | 714.22 | |
| Trade Receivables | 709.48 | 1,668.07 |
| Cash and Cash Equivalents (Bank Balances) | 5.1 | 0.48 |
| Loans other than Cash & Cash Equivalents | 124.32 | 117.94 |
| Total Current Assets (Excl. Tax) | 1167.43 | 951.51 |
| Current Tax Assets (Net) | 16.07 | 535 |
| Other Current Assets | 825.98 | 1,304.54 |
| Total Current Assets | 3562.6 | 4,047.89 |
| TOTAL - ASSETS | 3682.29 | 4,847.38 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity Share Capital | 1837.52 | 1,837.52 |
| Other Equity | 406.52 | (3.50) |
| Total Equity | 2244.04 | 1,834.02 |
| Liabilities | ||
| Borrowings (Non-current) | 184.95 | 735.35 |
| Borrowings (current) | 341.15 | 377.59 |
| Trade Payables | 869.67 | 1,830.06 |
| Other Current Liabilities | 42.48 | 7036 |
| TOTAL - EQUITY AND LIABILITIES | 3682.29 | 4,847.38 |
Cash Flow Summary
The audited statement of cash flow provides a detailed look at the sources and uses of funds for the fiscal year.| Particulars | For the year ended March 31, 2026 | For the year ended March 31, 2025 |
|---|---|---|
| A. Cash Flow From Operating Activities | ||
| Operating Profit before working capital changes | 248.10 | (48.27) |
| Cash Generated from Operations | (158.04) | 87.92 |
| Direct Tax Paid | (11.14) | 35.07 |
| Net Cash from Operating activities | (169.18) | 122.99 |
| B. Cash Flow From Investing Activities | ||
| Sales of Property, Plant & Equipments | 21212 | - |
| Sales / Redemption of Investments | 539.13 | - |
| Loans Given | (248.98) | (76.04) |
| Net Cash from Investing activities | 575.98 | (76.04) |
| C. Cash Flow from Financing activities | ||
| Net cash from Financing Activities | (356.35) | (48.71) |
| Net Increase/(Decrease) in cash & Cash Equivalents | 50.45 | (1.76) |
| Closing Balance of Cash & Cash equivalents | 50.93 | 0.48 |
Operational Update
The company confirmed that the Trading Window for dealing in securities of Vaxtex Cotfab Limited by all Designated Persons and their immediate relatives will be opened from Thursday, May 28, 2026, onwards.VCL Stock Price Movement
On Monday, Vaxtex Cotfab Limited shares edged higher to close at ₹1.42 after rallying 4.38% for the day. The stock saw robust investor interest, with trading volume reaching 260,620 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: